The American Journal of Psychiatry
Journal Home Search Current Issue Past Issues Subscribe All APPI Journals Help Contact Us
 
Am J Psychiatry 113:746-748, February 1957
doi: 10.1176/appi.ajp.113.8.746
© 1957 American Psychiatric Association
Quicksearch
Advanced Search
Or Search All APPI Journals
This Article
* Full Text (PDF)
* Alert me when this article is cited
* Alert me if a correction is posted
Services
* Email this article to a Colleague
* Similar articles in this journal
* Similar articles in PubMed
* Alert me to new issues of the journal
* Add to My Articles & Searches
* Download to citation manager
* reprints & permissions
Citing Articles
* Citing Articles via Google Scholar
Google Scholar
* Articles by SAMUELS, A. S.
* Search for Related Content
PubMed
* PubMed Citation
* Articles by SAMUELS, A. S.

CASE REPORTS

ACUTE CHLORPROMAZINE POISONING

ARTHUR S. SAMUELS M. D.1

1 The department of psychiatry and neurology, Tulane University School of Medicine, and the Charity Hospital of Louisiana, New Orleans, La.

The signs and symptoms of acute poisoning with chlorpromazine are similar to those reported for the antihistamines, to which it is chemically related. Poisoning is characterized most prominantly by central nervous system depression. In some cases there is also a phase of central nervous system stimulation with convulsions. Other prominent signs and symptoms may include marked hypotension to shock-like levels, tachycardia, tachypnea, hypothermia, diminished or absent reflexes, hypotonia, pinpoint pupils, stomatitis, blurred vision, and slurred speech. No permanent sequelae have been reported.

Treatment is primarily symptomatic. Because of the possibility of convulsions and postictal depression, the use of stimulant drugs is not recommended(2). Noradrenalin may be effectively used to counteract hypotension. Constant vigilance should be maintained to guard against respiratory failure, with artificial respiration the treatment of choice if failure should take place. A broad-spectrum antibiotic may be used to prevent secondary infection and intravenous fluids administered to maintain fluid balance.







Get information about faster international access.

Privacy Policy

Copyright © 1957 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us

American Psychiatric Publishing, Inc. American Psychiatric Association
1000 Wilson Boulevard, Suite 1825, Arlington, VA 22209-3901 * 800-368-5777 * appi at psych.org